The Indian Practitioner

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Hypertension : Burden, Awareness, and Control


Affiliations
1 President-Medical & Regulatory Affairs, Dept. of Scientific, Aristo Pharmaceuticals Private Limited, India
     

   Subscribe/Renew Journal


Hypertension is a highly prevalent modifiable cause of cardiovascular disease, stroke, and death. However, awareness, treatment, and control of high BP are very low, significantly increasing the risk of CVD and premature mortality and morbidity. Accuracy in BP measurement is critical, as even an error of 5-mmHg in measurement can lead to incorrect classification of hypertension in 84 million individuals worldwide. As the consequences of inaccurate BP measurement are grave, all the leading hypertension guidelines have placed a strong emphasis on accurate BP measurement. Achieving BP target goals is absolutely essential for significantly reducing composite cardiovascular outcomes in hypertensive patients.

Keywords

Cardiovascular Disease, Hypertension, Control, Blood Pressure, Target Goals, Measurement.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Nguyen TN& ChowCK, Global and national high blood pressure burden and control. Lancet.2021 Sep 11;398(10304):932-933.doi: 10.1016/S0140-6736(21)01688-3.

  • Kumar V, AgarwalS, Saboo B & Makkar B, RSSDI Guidelines for the management of hypertension in patients with diabetes mellitus. Int J Diabetes Dev Ctries 2022 Dec 15;42(Suppl 1):1-30. doi: 10.1007/s13410-022-01143-7.

  • EttehadD,et al. Blood pressure lowering for prevention of cardiovascular disease and death: A systematic review and meta-analysis. Lancet.2016 Mar 5;387(10022):957-967.doi: 10.1016/S0140-6736(15)01225-8.

  • Ramakrishnan S,et al. Prevalence of hypertension among Indian adults: Results from the great India blood pressure survey. Indian Heart J. 2019 Jul-Aug;71(4):309-313.doi: 10.1016/j.ihj.2019.09.012.

  • Gupta R & XavierD, Hypertension: The most important non communicable disease risk factor in India.Indian Heart J. 2018 Jul-Aug;70(4):565-572.doi: 10.1016/j.ihj.2018.02.003.

  • GeevarZ,et al. Prevalence, Awareness, Treatment, and Control of Hypertension in Young Adults (20–39 Years) in Kerala, South India. Front. Cardiovasc. Med.2022 Apr 18; 9:765442. doi: 10.3389/fcvm.2022.765442.

  • AnchalaR,et al. Hypertension in India: A systematic review and meta-analysis of prevalence, awareness, and control of hypertension. J. Hypertens.2014 Jun;32(6):1170-7.doi: 10.1097/HJH.0000000000000146.

  • https://www.who.int/india/health-topics/hypertension

  • Wu CY,et al. High blood pressure and all-cause and cardiovascular disease mortalities in community-dwelling older adults.Medicine (Baltimore). 2015 Nov;94(47):e2160. doi: 10.1097/MD.0000000000002160.

  • https://www.who.int/india/news/detail/02-06-2022-india-hypertension-control-initiative--a-high-impact-and-low-cost-solution.

  • FuchsFD& WheltonPK, High Blood Pressure and Cardiovascular Disease. Hypertension 285–292 (2020) doi:10.1161/HYPERTENSIONAHA.119.14240.

  • PadwalR,et al. Optimizing observer performance of clinic blood pressuremeasurement: A position statement fromthe Lancet Commission on Hypertension Group. J. Hypertens.2019 Sep;37(9):1737-1745.doi: 10.1097/HJH.0000000000002112.

  • WheltonPK,et al. Harmonization of the American College of Cardiology/American Heart Association and European Society of Cardiology/European Society of Hypertension Blood Pressure/Hypertension Guidelines. Eur. Heart J.2022 Sep 14;43(35):3302-3311.doi: 10.1093/eurheartj/ehac432.

  • UngerT,et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension 75.2020 Jun;75(6):1334-1357.doi:10.1161/HYPERTENSIONAHA.120.15026.

  • Adler A,et al. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis. Lancet 397, 1625–1636 (2021). doi: 10.1016/S0140-6736(21)00590-0.

  • ManciaG,et al. 2018 ESC/ESHGuidelines for themanagement ofarterial hypertension. J. Hypertens. 25, 2007 Jun;25(6):1105-87.doi: 10.1097/HJH.0b013e3281fc975a.

  • KoyaSF,et al. Hypertension control rate in India: systematic review and meta-analysis of population-level non-interventional studies, 2001–2022. Lancet Reg. Heal. - Southeast Asia 9, 100113 (2023).

  • Group, SPRINT Research, Jackson T. Wright, Jr., M.D., Ph.D., J. et al. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N. Engl. J. Med.2015 Nov 26;373(22):2103-16.doi: 10.1056/NEJMoa1511939.


Abstract Views: 141

PDF Views: 0




  • Hypertension : Burden, Awareness, and Control

Abstract Views: 141  |  PDF Views: 0

Authors

Manish Maladkar
President-Medical & Regulatory Affairs, Dept. of Scientific, Aristo Pharmaceuticals Private Limited, India

Abstract


Hypertension is a highly prevalent modifiable cause of cardiovascular disease, stroke, and death. However, awareness, treatment, and control of high BP are very low, significantly increasing the risk of CVD and premature mortality and morbidity. Accuracy in BP measurement is critical, as even an error of 5-mmHg in measurement can lead to incorrect classification of hypertension in 84 million individuals worldwide. As the consequences of inaccurate BP measurement are grave, all the leading hypertension guidelines have placed a strong emphasis on accurate BP measurement. Achieving BP target goals is absolutely essential for significantly reducing composite cardiovascular outcomes in hypertensive patients.

Keywords


Cardiovascular Disease, Hypertension, Control, Blood Pressure, Target Goals, Measurement.

References